Facility Limitation Considerations

Allison Cacciatore, Executive Director, Facilities Design & Engineering

Capacity is a concern at parenteral suppliers as we work towards success in developing a global COVID-19 vaccine. Drug manufacturers and contract fillers are working together to address capacity limitations.


Justifying ROI for QbD

Bikash Chatterjee, President & CSO

Within the last year we have seen our share of quality issues hit the airwaves. The troubles in India with Ranbaxy and Wockhardt have spurred some excellent discussion of how to drive the concepts of quality home within pharma.


Quality Circle: Profitability, Integrity and the Cost of Poor Quality

Bikash Chatterjee, President & CSO

As major blockbuster drugs come off patent, the scramble among generics to capture these new markets is just beginning. We can expect the U.S. market to experience continued change and consolidation with cost cutting remaining at the top of the priority list for big pharma.